Logo

HDC Raises Net from Stock Sale to $2.6M

Oct 04, 2007
NEW YORK (GenomeWeb News) - Health Discovery Corporation said today it has received more than $450,000 in additional common equity to add to $2.1 million it received last month in a common stock sale.
 
The company said today it has raised a total of $2.55 million in recent investments. Including $2.1 million in existing secured debt it converted into common or preferred stock, it has increased its coffers to $4.7 million.
 
The company said last month it plans to use the new capital to “focus on executing a business plan that features more biomarker discoveries, licensing and development opportunities, and continued enhancement and protection of our valuable patent estate.”
 
“We now have the financial staying power to fully exploit many of our opportunities,” said HDC’s CEO, Stephen Barnhill.
Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.